The role of oestrogen and progesterone receptors in gigantomastia

Introduction Gigantomastia is a rare condition characterised by excessive breast growth. The pathophysiology of mammary enlargement varies depending on the type of gigantomastia: gestational, juvenile virginal, or idiopathic. The study aimed at examining the receptor status (oestrogen receptor alpha...

Full description

Bibliographic Details
Main Authors: Anna Kasielska-Trojan, Marian Danilewicz, Jerzy Strużyna, Magdalena Bugaj, Bogusław Antoszewski
Format: Article
Language:English
Published: Termedia Publishing House 2019-09-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/The-role-of-oestrogen-and-progesterone-receptors-in-gigantomastia,108691,0,2.html
_version_ 1827620306179588096
author Anna Kasielska-Trojan
Marian Danilewicz
Jerzy Strużyna
Magdalena Bugaj
Bogusław Antoszewski
author_facet Anna Kasielska-Trojan
Marian Danilewicz
Jerzy Strużyna
Magdalena Bugaj
Bogusław Antoszewski
author_sort Anna Kasielska-Trojan
collection DOAJ
description Introduction Gigantomastia is a rare condition characterised by excessive breast growth. The pathophysiology of mammary enlargement varies depending on the type of gigantomastia: gestational, juvenile virginal, or idiopathic. The study aimed at examining the receptor status (oestrogen receptor alpha [ERα] and progesterone receptor [PR]) of breast tissue in adult women with juvenile or idiopathic gigantomastia. Material and methods The study involved 70 women who underwent breast reduction due to juvenile or idiopathic gigantomastia. Control breast specimens were obtained from 18 female cadavers. ERα and PR expressions were detected immunohistochemically in breast gland samples. Results Categorised and uncategorised ERα and PR expression did not differ between women with gigantomastia and control women. It was found that in both groups weak (0–30%) ERα and PR expression was the most common. Analysis of categorised data also did not reveal any significant correlations between ERα or PR and the women’s age: for the whole group: p = 0.795 (ERα), p = 0.207 (PR), for women with gigantomastia: p = 0.934 (ERα), p = 0.43 (PR), and for control women: p = 0.638 (ERα), p = 0.805 (PR). Conclusions Gigantomastia is not caused by increased expression of ERα and PR. Analysing abnormal sensitivity of these receptors to hormones may be crucial in establishing the increased risk of breast cancer in women with gigantomastia.
first_indexed 2024-03-09T10:46:29Z
format Article
id doaj.art-6ec504c1220a4524b5c38724d8b2a79a
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-03-09T10:46:29Z
publishDate 2019-09-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-6ec504c1220a4524b5c38724d8b2a79a2023-12-01T10:02:33ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512019-09-011841016102010.5114/aoms.2019.88280108691The role of oestrogen and progesterone receptors in gigantomastiaAnna Kasielska-Trojan0Marian Danilewicz1Jerzy Strużyna2Magdalena Bugaj3Bogusław Antoszewski4Plastic, Reconstructive and Aesthetic Surgery Clinic, Medical University of Lodz, PolandDepartment of Pathology, Medical University of Lodz, PolandEastern Centre of the Burns Treatment and Reconstructive Surgery in Łęczna, PolandEastern Centre of the Burns Treatment and Reconstructive Surgery in Łęczna, PolandPlastic, Reconstructive and Aesthetic Surgery Clinic, Medical University of Lodz, PolandIntroduction Gigantomastia is a rare condition characterised by excessive breast growth. The pathophysiology of mammary enlargement varies depending on the type of gigantomastia: gestational, juvenile virginal, or idiopathic. The study aimed at examining the receptor status (oestrogen receptor alpha [ERα] and progesterone receptor [PR]) of breast tissue in adult women with juvenile or idiopathic gigantomastia. Material and methods The study involved 70 women who underwent breast reduction due to juvenile or idiopathic gigantomastia. Control breast specimens were obtained from 18 female cadavers. ERα and PR expressions were detected immunohistochemically in breast gland samples. Results Categorised and uncategorised ERα and PR expression did not differ between women with gigantomastia and control women. It was found that in both groups weak (0–30%) ERα and PR expression was the most common. Analysis of categorised data also did not reveal any significant correlations between ERα or PR and the women’s age: for the whole group: p = 0.795 (ERα), p = 0.207 (PR), for women with gigantomastia: p = 0.934 (ERα), p = 0.43 (PR), and for control women: p = 0.638 (ERα), p = 0.805 (PR). Conclusions Gigantomastia is not caused by increased expression of ERα and PR. Analysing abnormal sensitivity of these receptors to hormones may be crucial in establishing the increased risk of breast cancer in women with gigantomastia.https://www.archivesofmedicalscience.com/The-role-of-oestrogen-and-progesterone-receptors-in-gigantomastia,108691,0,2.htmloestrogen receptorprogesterone receptorgigantomastia
spellingShingle Anna Kasielska-Trojan
Marian Danilewicz
Jerzy Strużyna
Magdalena Bugaj
Bogusław Antoszewski
The role of oestrogen and progesterone receptors in gigantomastia
Archives of Medical Science
oestrogen receptor
progesterone receptor
gigantomastia
title The role of oestrogen and progesterone receptors in gigantomastia
title_full The role of oestrogen and progesterone receptors in gigantomastia
title_fullStr The role of oestrogen and progesterone receptors in gigantomastia
title_full_unstemmed The role of oestrogen and progesterone receptors in gigantomastia
title_short The role of oestrogen and progesterone receptors in gigantomastia
title_sort role of oestrogen and progesterone receptors in gigantomastia
topic oestrogen receptor
progesterone receptor
gigantomastia
url https://www.archivesofmedicalscience.com/The-role-of-oestrogen-and-progesterone-receptors-in-gigantomastia,108691,0,2.html
work_keys_str_mv AT annakasielskatrojan theroleofoestrogenandprogesteronereceptorsingigantomastia
AT mariandanilewicz theroleofoestrogenandprogesteronereceptorsingigantomastia
AT jerzystruzyna theroleofoestrogenandprogesteronereceptorsingigantomastia
AT magdalenabugaj theroleofoestrogenandprogesteronereceptorsingigantomastia
AT bogusławantoszewski theroleofoestrogenandprogesteronereceptorsingigantomastia
AT annakasielskatrojan roleofoestrogenandprogesteronereceptorsingigantomastia
AT mariandanilewicz roleofoestrogenandprogesteronereceptorsingigantomastia
AT jerzystruzyna roleofoestrogenandprogesteronereceptorsingigantomastia
AT magdalenabugaj roleofoestrogenandprogesteronereceptorsingigantomastia
AT bogusławantoszewski roleofoestrogenandprogesteronereceptorsingigantomastia